1. Home
  2. AG vs CNTA Comparison

AG vs CNTA Comparison

Compare AG & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AG
  • CNTA
  • Stock Information
  • Founded
  • AG 1979
  • CNTA 2020
  • Country
  • AG Canada
  • CNTA United Kingdom
  • Employees
  • AG N/A
  • CNTA N/A
  • Industry
  • AG Precious Metals
  • CNTA Biotechnology: Pharmaceutical Preparations
  • Sector
  • AG Basic Materials
  • CNTA Health Care
  • Exchange
  • AG Nasdaq
  • CNTA Nasdaq
  • Market Cap
  • AG 1.9B
  • CNTA 2.3B
  • IPO Year
  • AG N/A
  • CNTA 2021
  • Fundamental
  • Price
  • AG $5.46
  • CNTA $17.16
  • Analyst Decision
  • AG Buy
  • CNTA Strong Buy
  • Analyst Count
  • AG 2
  • CNTA 7
  • Target Price
  • AG $7.50
  • CNTA $23.71
  • AVG Volume (30 Days)
  • AG 9.0M
  • CNTA 705.7K
  • Earning Date
  • AG 02-20-2025
  • CNTA 11-12-2024
  • Dividend Yield
  • AG 0.33%
  • CNTA N/A
  • EPS Growth
  • AG N/A
  • CNTA N/A
  • EPS
  • AG N/A
  • CNTA N/A
  • Revenue
  • AG $525,212,999.00
  • CNTA $6,853,000.00
  • Revenue This Year
  • AG N/A
  • CNTA N/A
  • Revenue Next Year
  • AG $28.06
  • CNTA N/A
  • P/E Ratio
  • AG N/A
  • CNTA N/A
  • Revenue Growth
  • AG N/A
  • CNTA N/A
  • 52 Week Low
  • AG $4.17
  • CNTA $6.65
  • 52 Week High
  • AG $8.44
  • CNTA $18.97
  • Technical
  • Relative Strength Index (RSI)
  • AG 34.11
  • CNTA 50.89
  • Support Level
  • AG $5.42
  • CNTA $16.02
  • Resistance Level
  • AG $6.78
  • CNTA $18.12
  • Average True Range (ATR)
  • AG 0.27
  • CNTA 1.08
  • MACD
  • AG -0.08
  • CNTA -0.08
  • Stochastic Oscillator
  • AG 2.45
  • CNTA 41.42

About AG First Majestic Silver Corp. (Canada)

First Majestic Silver Corp is engaged in the production, development, exploration, and acquisition of mineral properties with a focus on silver and gold production in North America. It owns three producing mines, in Mexico consisting of the San Dimas Silver/Gold Mine, the Santa Elena Silver/Gold Mine and the La Encantada Silver Mine.

About CNTA Centessa Pharmaceuticals plc

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.

Share on Social Networks: